UPST - FSLY UPST and XSPA among pre market gainers
Celyad Oncology (NASDAQ:CYAD) +31% raises $32.5M in private placement with Fortress Investment Group. Longeveron (NASDAQ:LGVN) +26% on FDA orphan designation to Lomecel-B Marvell Technology (NASDAQ:MRVL) +22% after third-quarter earnings beat Code Chain New Continent (NASDAQ:CCNC) +11%. Zillow (NASDAQ:Z) +10% updates progress on Zillow Offers inventory wind-down, authorizes $750M in share repurchase Cardiol Therapeutics (NASDAQ:CRDL) +8%. Aurora Mobile (NASDAQ:JG) +7%. Tivic Health (NASDAQ:TIVC) +7%. PetVivo Holdings (NASDAQ:PETV) +6%. Huaneng Power International (NYSE:HNP) +6%. Marpai (NASDAQ:MRAI) +6%. Fastly (NYSE:FSLY) +6%. Upstart (NASDAQ:UPST) +6%. iSpecimen (NASDAQ:ISPC) +6% expands supplier network of human biospecimens to help advance research in neurological disorders Moderna (NASDAQ:MRNA) +6% FDA to speed up review of Omicron-specific vaccines and drugs - WSJ XpresSpa Group (NASDAQ:XSPA) +6%. Novavax (NASDAQ:NVAX) +6% Prior infection may not protect against Omicron COVID variant: S. Africa microbiologist Meta Materials (NASDAQ:MMAT) +5%. UiPath (NYSE:PATH) +5% gets upgraded to overweight at Morgan Stanley, $74 PT
For further details see:
FSLY, UPST and XSPA among pre market gainers